DECITABINE, FILGRASTIM, CLADRIBINE, CYTARABINE, AND MITOXANTRONE HYDROCHLORIDE IN TREATING PATIENTS WITH NEWLY DIAGNOSED, RELAPSED, OR REFRACTORY ACUTE MYELOID LEUKEMIA OR HIGH-RISK MYELODYSPLASTIC SYNDROME: